The integrins alpha(v)beta(5) and alpha(v)beta(3) are expressed recipr
ocally during murine osteoclastogenesis in vitro. Specifically, immatu
re osteoclast precursors, in the form of bone marrow macrophages, cont
ain exclusively alpha(v)beta(5), surface expression of which declines
with commitment to the osteoclast phenotype, while levels of alpha(v)b
eta(3) increase concomitantly. The distinct functional significance of
alpha(v)beta(5) is underscored by the integrin's capacity, unlike alp
ha(v)beta(3), to mediate both attachment and spreading on ligand, of m
arrow macrophages, suggesting alpha(v)beta(3), negotiates initial reco
gnition, by osteoclast precursors, of bone matrix, Northern analysis d
emonstrates changes in the two beta-subunits, and not alpha(v), are re
sponsible for these alterations. Treatment of early precursors with gr
anulocyte-macrophage colony stimulating factor (GM-CSF) leads to alter
ations in beta(3) and beta(5) mRNA and alpha(v)beta(5) and alpha(v)bet
a(3), paralleling those occurring during osteoclastogenesis. Nuclear r
un-on and message stability studies demonstrate that while GM-CSF trea
tment of precursors alters beta(5) transcriptionally, the changes in b
eta(3) arise from prolonged mRNA t(1/2). Similar to GM-CSF treatment,
the rate of beta(5) transcription falls during authentic osteoclastoge
nesis. In contrast to cytokine-induced alpha(v)beta(3), however, that
attending osteoclastogenesis reflects accelerated transcription of the
beta(3)-subunit, Thus, while GM-CSF may participate in modulation of
alpha(v)beta(5) during osteoclast differentiation, signals other than
those derived from the cytokine must regulate expression of alpha(v)be
ta(3).